Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

L.Pereira de Almeida; D. Zala; P. Aebischer; N. Déglon

doi:10.1006/nbdi.2001.0388

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

Neurobiology of Disease ◽

10.1006/nbdi.2001.0388 ◽

2001 ◽

Vol 8 (3) ◽

pp. 433-446 ◽

Cited By ~ 105

Author(s):

L.Pereira de Almeida ◽

D. Zala ◽

P. Aebischer ◽

N. Déglon

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Quinolinic Acid ◽

Lentiviral Vector ◽

Neuroprotective Effect

Download Full-text

Dose-Dependent Neuroprotective Effect of Ciliary Neurotrophic Factor Delivered via Tetracycline-Regulated Lentiviral Vectors in the Quinolinic Acid Rat Model of Huntington's Disease

Human Gene Therapy ◽

10.1089/10430340260355383 ◽

2002 ◽

Vol 13 (16) ◽

pp. 1981-1990 ◽

Cited By ~ 80

Author(s):

E. Régulier ◽

L. Pereira de Almeida ◽

B. Sommer ◽

P. Aebischer ◽

N. Déglon

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Quinolinic Acid ◽

Neurotrophic Factor ◽

Neuroprotective Effect ◽

Lentiviral Vectors ◽

Ciliary Neurotrophic Factor ◽

Dose Dependent

Download Full-text

Comparison of Transplant Efficiency between Spontaneously Derived and Noggin-Primed Human Embryonic Stem Cell Neural Precursors in the Quinolinic Acid Rat Model of Huntington's Disease

Cell Transplantation ◽

10.3727/096368910x494632 ◽

2010 ◽

Vol 19 (8) ◽

pp. 1055-1062 ◽

Cited By ~ 26

Author(s):

Elena M. Vazey ◽

Mirella Dottori ◽

Pegah Jamshidi ◽

Doris Tomas ◽

Martin F. Pera ◽

...

Keyword(s):

Stem Cell ◽

Embryonic Stem Cell ◽

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Quinolinic Acid ◽

Human Embryonic Stem Cell ◽

Embryonic Stem ◽

Neural Precursors

Download Full-text

Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington’s disease

Brain Research ◽

10.1016/s0006-8993(03)02942-1 ◽

2003 ◽

Vol 979 (1-2) ◽

pp. 225-229 ◽

Cited By ~ 16

Author(s):

Marco Gianfriddo ◽

Claudia Corsi ◽

Alessia Melani ◽

Antonella Pèzzola ◽

Rosaria Reggio ◽

...

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Quinolinic Acid ◽

Adenosine A2a

Download Full-text

Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala 2 GIP in rat model of Huntington's disease

European Journal of Pharmacology ◽

10.1016/j.ejphar.2018.03.034 ◽

2018 ◽

Vol 828 ◽

pp. 31-41 ◽

Cited By ~ 7

Author(s):

Mahip K. Verma ◽

Rajan Goel ◽

Krishnadas Nandakumar ◽

Kumar V.S. Nemmani

Keyword(s):

Lipid Peroxidation ◽

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Quinolinic Acid ◽

Receptor Agonist ◽

Neurobehavioral Deficits ◽

Gip Receptor

Download Full-text

77. Dose-Dependent Neuroprotective Effect of CNTF Delivered Via Tetracycline-Regulated Lentiviral Vectors in the Quinolonic Acid Rat Model of Huntington's Disease

Molecular Therapy ◽

10.1016/s1525-0016(16)42907-2 ◽

2002 ◽

Vol 5 (5) ◽

pp. S28

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Rat Model ◽

Neuroprotective Effect ◽

Lentiviral Vectors ◽

Dose Dependent

Download Full-text

Huntington’s Disease and Neural Transplantation: GABAA Receptor Changes in the Basal Ganglia in Huntington’s Disease in the Human Brain and in the Quinolinic Acid Lesioned Rat Model of the Disease Following Fetal Neuron Transplants

Advances in Behavioral Biology - Neurotransmitters in the Human Brain ◽

10.1007/978-1-4615-1853-2_11 ◽

1995 ◽

pp. 173-197 ◽

Cited By ~ 5

Author(s):

R. L. M. Faull ◽

H. J. Waldvogel ◽

L. F. B. Nicholson ◽

M. N. Williams ◽

M. Dragunow

Keyword(s):

Basal Ganglia ◽

Human Brain ◽

Huntington's Disease ◽

Huntington’S Disease ◽

Gabaa Receptor ◽

Rat Model ◽

Quinolinic Acid ◽

Neural Transplantation

Download Full-text

P3-491: NEUROPROTECTIVE EFFECT OF NARINGIN IN QUINOLINIC ACID-INDUCED HUNTINGTON'S DISEASE: ROLE OF BAX/BCL-2 AND CASPASE-3

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.06.1855 ◽

2006 ◽

Vol 14 (7S_Part_24) ◽

pp. P1310-P1310

Author(s):

Anwesha A. Mukherjee ◽

Amit D. Kandhare ◽

Subhash L. Bodhankar

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Quinolinic Acid ◽

Caspase 3 ◽

Neuroprotective Effect

Download Full-text

Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington’s disease

Behavioural Brain Research ◽

10.1016/j.bbr.2003.10.021 ◽

2004 ◽

Vol 152 (2) ◽

pp. 375-383 ◽

Cited By ~ 22

Author(s):

Maria Luisa Scattoni ◽

Angelina Valanzano ◽

Patrizia Popoli ◽

Antonella Pezzola ◽

Rosaria Reggio ◽

...

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Open Field ◽

Rat Model ◽

Quinolinic Acid ◽

Behavioural Changes

Download Full-text

Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease

Brain Research ◽

10.1016/s0006-8993(97)01428-5 ◽

1998 ◽

Vol 787 (1) ◽

pp. 143-148 ◽

Cited By ~ 24

Author(s):

D Joel ◽

L Ayalon ◽

R Tarrasch ◽

L Veenman ◽

J Feldon ◽

...

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Globus Pallidus ◽

Rat Model ◽

Quinolinic Acid ◽

Electrolytic Lesion ◽

Novel Treatment

Download Full-text

Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease

Movement Disorders ◽

10.1002/mds.10622 ◽

2003 ◽

Vol 18 (12) ◽

pp. 1499-1507 ◽

Cited By ~ 7

Author(s):

Daphna Joel ◽

Liat Ayalon ◽

Ricardo Tarrasch ◽

Ina Weiner

Keyword(s):

Huntington's Disease ◽

Huntington’S Disease ◽

Globus Pallidus ◽

Rat Model ◽

Quinolinic Acid ◽

Reversal Task ◽

Novel Treatment ◽

Position Discrimination

Download Full-text